시장조사 보고서 : 세계의 혈우병 유전자 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00120 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 혈우병 유전자 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B)와 용도별 시장규모 (혈우병 A 유전자 치료, 혈우병 B 유전자 치료) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 혈우병 유전자 치료 시장 점유율
- 지역별 혈우병 유전자 치료 시장규모
- 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B)
- 주요지역의 용도별 시장규모 (혈우병 A 유전자 치료, 혈우병 B 유전자 치료)
- 미주의 혈우병 유전자 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 혈우병 유전자 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 혈우병 유전자 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 혈우병 유전자 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 혈우병 유전자 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, BioMarin, uniQure, Freeline Therapeutics
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hemophilia Gene Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hemophilia Gene Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Hemophilia A
Hemophilia B

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hemophilia A Gene Therapy
Hemophilia B Gene Therapy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Spark Therapeutics
Ultragenyx
Shire PLC
Sangamo Therapeutics
Bioverativ
BioMarin
uniQure
Freeline Therapeutics

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size 2016-2026
2.1.2 Hemophilia Gene Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hemophilia Gene Therapy Segment by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia A
2.3 Hemophilia Gene Therapy Market Size by Type
2.3.1 Global Hemophilia Gene Therapy Market Size CAGR by Type
2.3.2 Global Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
2.4 Hemophilia Gene Therapy Segment by Application
2.4.1 Hemophilia A Gene Therapy
2.4.2 Hemophilia B Gene Therapy
2.5 Hemophilia Gene Therapy Market Size by Application
2.5.1 Global Hemophilia Gene Therapy Market Size CAGR by Application
2.5.2 Global Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)

3 Hemophilia Gene Therapy Market Size by Players
3.1 Hemophilia Gene Therapy Market Size Market Share by Players
3.1.1 Global Hemophilia Gene Therapy Revenue by Players (2019-2021E)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Hemophilia Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hemophilia Gene Therapy by Regions
4.1 Hemophilia Gene Therapy Market Size by Regions (2016-2021)
4.2 Americas Hemophilia Gene Therapy Market Size Growth (2016-2021)
4.3 APAC Hemophilia Gene Therapy Market Size Growth (2016-2021)
4.4 Europe Hemophilia Gene Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Hemophilia Gene Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hemophilia Gene Therapy Market Size by Country (2016-2021)
5.2 Americas Hemophilia Gene Therapy Market Size by Type (2016-2021)
5.3 Americas Hemophilia Gene Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hemophilia Gene Therapy Market Size by Region (2016-2021)
6.2 APAC Hemophilia Gene Therapy Market Size by Type (2016-2021)
6.3 APAC Hemophilia Gene Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hemophilia Gene Therapy by Country (2016-2021)
7.2 Europe Hemophilia Gene Therapy Market Size by Type (2016-2021)
7.3 Europe Hemophilia Gene Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hemophilia Gene Therapy by Region (2016-2021)
8.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hemophilia Gene Therapy Market Forecast
10.1 Global Hemophilia Gene Therapy Forecast by Regions (2021-2026)
10.1.1 Global Hemophilia Gene Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Hemophilia Gene Therapy Forecast
10.1.3 APAC Hemophilia Gene Therapy Forecast
10.1.4 Europe Hemophilia Gene Therapy Forecast
10.1.5 Middle East & Africa Hemophilia Gene Therapy Forecast
10.2 Americas Hemophilia Gene Therapy Forecast by Countries (2021-2026)
10.2.1 United States Hemophilia Gene Therapy Market Forecast
10.2.2 Canada Hemophilia Gene Therapy Market Forecast
10.2.3 Mexico Hemophilia Gene Therapy Market Forecast
10.2.4 Brazil Hemophilia Gene Therapy Market Forecast
10.3 APAC Hemophilia Gene Therapy Forecast by Region (2021-2026)
10.3.1 China Hemophilia Gene Therapy Market Forecast
10.3.2 Japan Hemophilia Gene Therapy Market Forecast
10.3.3 Korea Hemophilia Gene Therapy Market Forecast
10.3.4 Southeast Asia Hemophilia Gene Therapy Market Forecast
10.3.5 India Hemophilia Gene Therapy Market Forecast
10.3.6 Australia Hemophilia Gene Therapy Market Forecast
10.4 Europe Hemophilia Gene Therapy Forecast by Country (2021-2026)
10.4.1 Germany Hemophilia Gene Therapy Market Forecast
10.4.2 France Hemophilia Gene Therapy Market Forecast
10.4.3 UK Hemophilia Gene Therapy Market Forecast
10.4.4 Italy Hemophilia Gene Therapy Market Forecast
10.4.5 Russia Hemophilia Gene Therapy Market Forecast
10.5 Middle East & Africa Hemophilia Gene Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Hemophilia Gene Therapy Market Forecast
10.5.2 South Africa Hemophilia Gene Therapy Market Forecast
10.5.3 Israel Hemophilia Gene Therapy Market Forecast
10.5.4 Turkey Hemophilia Gene Therapy Market Forecast
10.5.5 GCC Countries Hemophilia Gene Therapy Market Forecast
10.6 Global Hemophilia Gene Therapy Forecast by Type (2021-2026)
10.7 Global Hemophilia Gene Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Information
11.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Offered
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Spark Therapeutics Main Business Overview
11.1.5 Spark Therapeutics Latest Developments
11.2 Ultragenyx
11.2.1 Ultragenyx Company Information
11.2.2 Ultragenyx Hemophilia Gene Therapy Product Offered
11.2.3 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Ultragenyx Main Business Overview
11.2.5 Ultragenyx Latest Developments
11.3 Shire PLC
11.3.1 Shire PLC Company Information
11.3.2 Shire PLC Hemophilia Gene Therapy Product Offered
11.3.3 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Shire PLC Main Business Overview
11.3.5 Shire PLC Latest Developments
11.4 Sangamo Therapeutics
11.4.1 Sangamo Therapeutics Company Information
11.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Sangamo Therapeutics Main Business Overview
11.4.5 Sangamo Therapeutics Latest Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Information
11.5.2 Bioverativ Hemophilia Gene Therapy Product Offered
11.5.3 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Bioverativ Main Business Overview
11.5.5 Bioverativ Latest Developments
11.6 BioMarin
11.6.1 BioMarin Company Information
11.6.2 BioMarin Hemophilia Gene Therapy Product Offered
11.6.3 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 BioMarin Main Business Overview
11.6.5 BioMarin Latest Developments
11.7 uniQure
11.7.1 uniQure Company Information
11.7.2 uniQure Hemophilia Gene Therapy Product Offered
11.7.3 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 uniQure Main Business Overview
11.7.5 uniQure Latest Developments
11.8 Freeline Therapeutics
11.8.1 Freeline Therapeutics Company Information
11.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Offered
11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Freeline Therapeutics Main Business Overview
11.8.5 Freeline Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hemophilia Gene Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Hemophilia A
Table 3. Major Players of Hemophilia B
Table 4. Hemophilia Gene Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Hemophilia Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
Table 7. Hemophilia Gene Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Hemophilia Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)
Table 10. Global Hemophilia Gene Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Hemophilia Gene Therapy Revenue Market Share by Players (2019-2021E)
Table 12. Hemophilia Gene Therapy Key Players Head office and Products Offered
Table 13. Hemophilia Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hemophilia Gene Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Hemophilia Gene Therapy Market Size Market Share by Regions 2016-2021
Table 18. Americas Hemophilia Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Hemophilia Gene Therapy Market Size Market Share by Country (2016-2021)
Table 20. Americas Hemophilia Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
Table 22. Americas Hemophilia Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)
Table 24. APAC Hemophilia Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Hemophilia Gene Therapy Market Size Market Share by Region (2016-2021)
Table 26. APAC Hemophilia Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
Table 28. APAC Hemophilia Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)
Table 30. Europe Hemophilia Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Hemophilia Gene Therapy Market Size Market Share by Country (2016-2021)
Table 32. Europe Hemophilia Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
Table 34. Europe Hemophilia Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Hemophilia Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Hemophilia Gene Therapy
Table 43. Key Application and Potential Industries of Hemophilia Gene Therapy
Table 44. Key Challenges of Hemophilia Gene Therapy
Table 45. Key Trends of Hemophilia Gene Therapy
Table 46. Global Hemophilia Gene Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Hemophilia Gene Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Hemophilia Gene Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 52. Spark Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 53. Spark Therapeutics Hemophilia Gene Therapy Product Offered
Table 54. Spark Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Spark Therapeutics Main Business
Table 56. Spark Therapeutics Latest Developments
Table 57. Ultragenyx Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 58. Ultragenyx Hemophilia Gene Therapy Product Offered
Table 59. Ultragenyx Main Business
Table 60. Ultragenyx Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Ultragenyx Latest Developments
Table 62. Shire PLC Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 63. Shire PLC Hemophilia Gene Therapy Product Offered
Table 64. Shire PLC Main Business
Table 65. Shire PLC Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Shire PLC Latest Developments
Table 67. Sangamo Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 68. Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
Table 69. Sangamo Therapeutics Main Business
Table 70. Sangamo Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Sangamo Therapeutics Latest Developments
Table 72. Bioverativ Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 73. Bioverativ Hemophilia Gene Therapy Product Offered
Table 74. Bioverativ Main Business
Table 75. Bioverativ Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Bioverativ Latest Developments
Table 77. BioMarin Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 78. BioMarin Hemophilia Gene Therapy Product Offered
Table 79. BioMarin Main Business
Table 80. BioMarin Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. BioMarin Latest Developments
Table 82. uniQure Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 83. uniQure Hemophilia Gene Therapy Product Offered
Table 84. uniQure Main Business
Table 85. uniQure Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. uniQure Latest Developments
Table 87. Freeline Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 88. Freeline Therapeutics Hemophilia Gene Therapy Product Offered
Table 89. Freeline Therapeutics Main Business
Table 90. Freeline Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Freeline Therapeutics Latest Developments
List of Figures
Figure 1. Hemophilia Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemophilia Gene Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hemophilia Gene Therapy Market Size Market Share by Type in 2020
Figure 7. Hemophilia Gene Therapy in Hemophilia A Gene Therapy
Figure 8. Global Hemophilia Gene Therapy Market: Hemophilia A Gene Therapy (2016-2021) & ($ Millions)
Figure 9. Hemophilia Gene Therapy in Hemophilia B Gene Therapy
Figure 10. Global Hemophilia Gene Therapy Market: Hemophilia B Gene Therapy (2016-2021) & ($ Millions)
Figure 11. Global Hemophilia Gene Therapy Market Size Market Share by Application in 2020
Figure 12. Global Hemophilia Gene Therapy Revenue Market Share by Player in 2020
Figure 13. Global Hemophilia Gene Therapy Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Hemophilia Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 15. APAC Hemophilia Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 16. Europe Hemophilia Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Hemophilia Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 18. Americas Hemophilia Gene Therapy Market Size Market Share by Country in 2020
Figure 19. Americas Hemophilia Gene Therapy Market Size Market Share by Type in 2020
Figure 20. Americas Hemophilia Gene Therapy Market Size Market Share by Application in 2020
Figure 21. United States Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Hemophilia Gene Therapy Market Size Market Share by Regions in 2020
Figure 25. APAC Hemophilia Gene Therapy Market Size Market Share by Type in 2020
Figure 26. APAC Hemophilia Gene Therapy Market Size Market Share by Application in 2020
Figure 27. China Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Hemophilia Gene Therapy Market Size Market Share by Country in 2020
Figure 34. Europe Hemophilia Gene Therapy Market Size Market Share by Type in 2020
Figure 35. Europe Hemophilia Gene Therapy Market Size Market Share by Application in 2020
Figure 36. Germany Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application in 2020
Figure 44. Egypt Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Hemophilia Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 50. APAC Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 51. Europe Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 53. United States Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 54. Canada Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 57. China Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Japan Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 59. Korea Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 61. India Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Australia Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 63. Germany Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 64. France Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 65. UK Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Italy Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 67. Russia Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Spain Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Israel Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Hemophilia Gene Therapy Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 혈우병 유전자 치료 시장예측 2021년-2026년] (코드 : LPI-2201K00120) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 혈우병 유전자 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년
LPI-2201K00119 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아,...According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth...

세계의 혈우병 치료제 시장예측 2021년-2026년
LPI-2201K00121 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hemophilia Therapeutics will have significant change from previous year. By the most conservative estimates of global Hemophilia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9275.3 million in 2020. Over...

세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년
LPI-2201K02238 / LP Information / 2021년 12월 / 본 조사보고서는 내추럴 킬러 세포 치료법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. By the most conservative estimates of global Natural Killer Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 201.5...

세계의 플라즈마 요법 시장예측 2021년-2026년
LPI-2201K02280 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Therapy will have significant change from previous year. By the most conservative estimates of global Plasma Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 239.8 million in 2020. Over...